The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
Self-citationDeletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,136
Roy, N., Mahadevan, M. S., McLean, M., Shutter, G., Yaraghi, Z., Farahani, R., Baird, S., Besner-Johnston, A., Lefebvre, C., Kang, X., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90461-1 · Cited by 981
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p Loss
Cairns, P., Mao, L., Merlo, A., Lee, D. J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J. E., & Sidransky, D. (1994) · Science · doi:10.1126/science.8023167 · Cited by 427
Self-citationDeletion of p16 and p15 genes in brain tumors.
Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S. D., Willson, J. K. V., Kinzler, K. W., & Vogelstein, B. (1994) · PubMed · Cited by 404
Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma.
Knudson, A. G., Hethcote, H. W., & Brown, B. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.12.5116 · Cited by 348
Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S., & Nakamura, Y. (1994) · PubMed · Cited by 333
Frequent loss of chromosome 9p21-22 early in head and neck cancer progression.
van der Riet, P., Nawroz, H., Hruban, R. H., Corio, R. L., Tokino, K., Koch, W. M., & Sidransky, D. (1994) · PubMed · Cited by 317
Self-citationHomozygous deletions within human chromosome band 9p21 in melanoma.
Fountain, J. W., Karayiorgou, M., Ernstoff, M. S., Kirkwood, J. M., Vlock, D. R., Titus-Ernstoff, L., Bouchard, B., Vijayasaradhi, S., Houghton, A. N., & Lahti, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10557 · Cited by 315
Deletions of Interferon Genes in Acute Lymphoblastic Leukemia
Diaz, M. O., Rubin, C. M., Harden, A., Ziemin, S., Larson, R. A., Le Beau, M. M., & Rowley, J. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220202 · Cited by 211
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)90160-4 · Cited by 205
Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
Cairns, P., Me, S., & Knowles, M. A. (1993) · PubMed · Cited by 188
Self-citationOhta, M., Nagai, H., Shimizu, M., Rasio, D., Berd, D., Mastrangelo, M. J., Singh, A. D., Shields, J. A., Shields, C. L., & Croce, C. M. (1994) · PubMed · Cited by 165
Cairns, P., Tokino, K., Eby, Y. J., & Sidransky, D. (1994) · PubMed · Cited by 163
Self-citationOlopade, O. I., Buchhagen, D. L., Malik, K., Sherman, J., Nobori, T., Bader, S. A., Nau, M. M., Gazdar, A. F., Minna, J. D., & Dı́az, M. O. (1993) · PubMed · Cited by 141
Hayashi, N., Sugimoto, Y., Tsuchiya, E., Ogawa, M., & Nakamura, Y. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2090 · Cited by 117
The MTS1 gene is frequently mutated in primary human esophageal tumors.
Zhou, X., Tarmin, L., Yin, J., Jiang, H. Y., Suzuki, H., Rhyu, M. G., Abraham, J. M., & Meltzer, S. J. (1994) · PubMed · Cited by 110
Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas.
Xu, L., Sgroi, D. C., Sterner, C. J., Beauchamp, R. L., Pinney, D., Keel, S. B., Ueki, K., Rutter, J. L., Buckler, A., & Louis, D. N. (1994) · PubMed · Cited by 108
Self-citationLocalization of a putative tumor suppressor gene by using homozygous deletions in melanomas.
Weaver-Feldhaus, J., Gruis, N. A., Neuhausen, S. L., Paslier, D. L., Stockert, E., Skolnick, M. H., & Kamb, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7563 · Cited by 62
Chromosome‐9 loss detected by fluorescence in situ hybridization in bladder cancer
Sauter, G., Moch, H., Carroll, P. R., Kerschmann, R., Mihatsch, M. J., & Waldman, F. M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640205 · Cited by 59
Zhang, J., Meltzer, P. S., Jenkins, R. B., Guan, X., & Trent, J. M. (1993) · Blood · doi:10.1182/blood.v81.12.3365.3365 · Cited by 52
Self-citationN‐ras‐like sequences on chromosomes 9, 6 and 22 with a polymorphism at the chromosome 9 locus
Middleton-Price, H. R., Spurr, N. K., Hall, A., & Malcolm, S. (1988) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1988.tb01096.x · Cited by 7
Cited by
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60702-2 · Cited by 1,928
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Metadata
- Authors
- Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J. L., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Isaacs, W., Koch, W., Schwab, D., & Sidransky, D.
- Venue
- Nature Genetics
- Published
- 1995-10
- Volume
- 11
- Issue
- 2
- Pages
- 210-212
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2067795112
- Cited by
- 627
- References
- 27
- FWCI
- 18.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.